| http://www.w3.org/ns/prov#value | - Anticancer Activity of SRI31215, a Novel Inhibitor of Hepatocyte Growth Factor (HGF) Activation Benjamin Owusu (Biochemisty & Cancer Biology, University of Alabama at Birmingham & Southern Research Institute) Aberrant Hepatocyte growth factor (HGF)/MET signaling has been implicated in the development and progression of several types of human cancers and in the development of resistance to therapy.
|
